Source: Medical Product Outsourcing

Vesper Medical: Vesper Medical Announces First Enrollment in the VIVID Trial

Company initiates pivotal clinical study for next-generation deep venous stent.

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
1-25
Bruce J Shook's photo - President & CEO of Vesper Medical

President & CEO

Bruce J Shook

CEO Approval Rating

86/100

Read more